Myocarditis and Dilated Cardiomyopathy

The Autoimmune Diseases: Fifth Edition

Volumn , Issue , 2013, Pages 1033-1048

  Rose, Noel R ^a   Kaya, Ziya ^b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Beta adrenoreceptor; Cardiac myosin; Dilated cardiomyopathy; Endomyocardial biopsy; Heart failure; Myocarditis; Troponin

Indexed keywords

EID: 84900550625     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-384929-8.00070-8     Document Type: Chapter

References (129)

1. Abdel-Aty H., Boye P., Zagrosek A., Wassmuth R., Kumar A., Messroghli D., et al. Diagnostic performance of cardiovascular magnetic resonance in patients with suspected acute myocarditis: comparison of different approaches. J. Am. Coll. Cardiol. 2005, 45:1815-1822.
2. Abelmann W.H. Classification and natural history of primary myocardial disease. Prog. Cardiovasc. Dis. 1984, 27:73-94.
3. Anderson J.L., Carlquist J.F., Lutz J.R., DeWitt C.W., Hammond E.H. HLA A, B and DR typing in idiopathic dilated cardiomyopathy: a search for immune response factors. Am. J. Cardiol. 1984, 53:473-487.
4. Ansari A.A., Herskowitz A., Danner D.J., Neckelmann N., Gershwin M.E., Gravanis M.B., et al. Identification of mitochondrial proteins that serve as targets for autoimmunity in human dilated cardiomyopathy. Circulation 1988, 78:457.
5. Aretz H.T., Billingham M.E., Edwards W.D., Factor S.M., Fallon J.T., Fenoglio J.J., et al. Myocarditis. A histopathologic definition and classification. Am. J. Cardiovasc. Pathol. 1986, 1:3-14.
6. Arola A., Jokinen E., Ruuskanen O., Saraste M., Pesonen E., Kuusela A.L., et al. Epidemiology of idiopathic cardiomyopathies in children and adolescents. A nationwide study in Finland. Am. J. Epidemiol. 1997, 146:385-393.
7. Ayuthya P.S.N., Jayavasu J., Pongpanich B. Coxsackie group B virus and primary myocardial disease in infants and children. Am. Heart J. 1974, 88:311-314.
8. Baboonian C., McKenna W. Eradication of viral myocarditis. Is there hope?. J. Am. Coll. Cardiol. 2003, 42:473-476.
9. Ballinas-Vedugo M.A., Alejandre-Aguilar R., Aranda-Fraustro A., Reyes P., Monteon M. Anti-myosin autoantibodies are more frequent in non-Chagas cardiomyopathy than in Chagasic cardiomyopathy patients. Int. J. Cardiol. 2003, 92:101-102.
10. Basso C., Calabrese F., Angelini A., Carturan E., Thiene G. Classification and histological, immunohistochemical, and molecular diagnosis of inflammatory myocardial disease. Heart Fail. Rev. 2012, 10.1007/s10741-012-9355-6.
11. Beck M.A., Shi Q., Morris V.C., Levander O.A. Rapid genomic evolution of a non-virulent Coxsackievirus B3 in selenium-deficient mice results in selection of identical virulent isolates. Nat. Med. 1995, 1:433-436.
12. Bowles N.E., Richardson P.J., Olsen E.G.J., Archard L.C. Detection of Coxsackie-B-virus-specific RNA sequences in myocardial biopsy samples from patients with myocarditis and dilated cardiomyopathy. Lancet. i 1986, 1120-1122.
13. Bowles N.E., Ni J., Kearney D.L., Pauschinger M., Schultheiss H.-P., McCarthy R., et al. Detection of viruses in myocardial tissues by polymerase chain reaction; evidence of adenovirus as a common cause of myocarditis in children and adults. J. Am. Coll. Cardiol. 2003, 42:466-472.
14. Burch G.E., Sun S.C., Chu K.C., Sohal R.S., Colcolough H.L. Interstitial and Coxsackievirus B myocarditis in infants and children. A comparative histologic and immunofluorescent study of 50 autopsied hearts. J. Am. Med. Assoc. 1968, 203:55-62.
15. Caforio A.L., Calabrese F., Angelini A., Tona F., Vinci A., Bottaro S., et al. A prospective study of biopsy-proven myocarditis: prognostic relevance of clinical and aetiopathogenetic features at diagnosis. Eur. Heart J. 2007, 28:1326-1333.
16. Caforio A.L.P., Grazzini M., Mann J.M., Keeling P.J., Bottazzo G.F., McKenna W.J., et al. Identification of a- and b-cardiac myosin heavy chain isoforms as major autoantigens in dilated cardiomyopathy. Circulation 1992, 85:1734-1742.
17. Caforio A.L.P., Mahon N.J., Tona F., McKenna W.J. Circulating cardiac autoantibodies in dilated cardiomyopathy and myocarditis: pathogenetic and clinical significance. Eur. J. Heart Failure 2002, 4:411-417.
18. Carlquist J.F., Menlove R.L., Murray M.B., O'Connell J.B., Anderson J.L. HLA class II (DR and DQ) antigen associations in idiopathic dilated cardiomyopathy. Circulation 1991, 83:515-522.
19. Cetta F., Michels V.V. The autoimmune basis of dilated cardiomyopathy. Ann. Med. 1995, 27:169-173.
20. Chen P., Baldeviano G.C., Ligons D.L., Talor M.V., Barin J.G., Rose N.R., et al. Susceptibility to autoimmune myocarditis is associated with intrinsic differences in CD4(+) T cells. Clin. Exp. Immunol. 2012, 169:79-88.
21. Chow L.H., Radio S.J., Sears T.D., McManus G.M. Insensitivity of right ventricular endomyocardial biopsy in the diagnosis of myocarditis. J. Am. Coll. Cardiol. 1989, 14:915-920.
22. Cihakova D., Rose N.R. Pathogenesis of myocarditis and dilated cardiomyopathy. Adv. Immunol. 2008, 99:95-114.
23. Cooper L.T. Idiopathic giant cell myocarditis. Myocarditis from Bench to Bedside 2002, 405-420. Humana Press, Totowa, NJ. L.T. Cooper (Ed.).
24. Coura J.R., Borges-Pereira J. Chagas disease: what is known and what should be improved: a systemic review. Rev. Soc. Bras. Med. Trop. 2012, 45:286-296.
25. Cunha-Neto E., Iwai L.K., Morand B., Bilate A., Goncalves-Fonseca S., Kalil J. Infection and Autoimmunity 2004, 449-466. Autoimmunity in Chagas' Disease, Elsevier, Amsterdam. Y. Shoenfeld, N.R. Rose (Eds.).
26. Cunningham M.W. T cell mimicry in inflammatory heart disease. Mol. Immunol. 2004, 40:1121-1127.
27. Cunningham M.W., Meissner H.C., Heuser J.S., Pietra B.A., Kurahara D.K., Leung D.Y.M. Anti-human cardiac myosin autoantibodies in Kawasaki syndrome. J. Immunol. 1999, 163:1060-1065.
28. Dandel M., Wallukat G., Potapov E., Hetzer R. Role of beta(1)-adrenoceptor autoantibodies in the pathogenesis of dilated cardiomyopathy. Immunobiology 2012, 217:511-520.
29. Dec G.W., Palacios I.F., Fallon J.T., Aretz H.T., Mills J., Lee D.C., et al. Active myocarditis in the spectrum of acute dilated cardiomyopathies. Clinical features, histologic correlates, and clinical outcome. N. Engl. J. Med. 1985, 312:885-890.
30. Deubner N., Berliner D., Schlipp A., Gelbrich G., Caforio A.L., Felix S.B., et al. Cardiac beta1-adrenoceptor autoantibodies in human heart disease: rationale and design of the Etiology, Titre-Course, and Survival (ETiCS) Study. Eur. J. Heart Fail 2010, 12:753-762.
31. D'Ambrosio A., Patti G., Manzoli A., Sinagra G., Di Lenarda A., Silvestri F., et al. The fate of acute myocarditis between spontaneous improvement and evolution to dilated cardiomyopathy: a review. Heart 2001, 85:499-504.
32. Elamm C., Fairweather D., Cooper L.T. Pathogenesis and diagnosis of myocarditis. Heart 2012, 98(11):835-840.
33. Esfandiarei M., McManus B.M. Molecular biology and pathogenesis of viral myocarditis. Annu. Rev. Pathol. 2008, 3:127-155.
34. Fabre A., Sheppard M.N. Sudden adult death syndrome and other non-ischaemic causes of sudden cardiac death. Heart. 2006, 92:316-320.
35. Fairweather D., Frisancho-Kiss S., Gatewood S., Njoku D., Steele R., Barrett M., et al. Mast cells and innate cytokines are associated with susceptibility to autoimmune heart disease following Coxsackievirus B3 infection. Autoimmunity 2004, 37:131-145.
36. Fairweather D., Afanasyeva M., Rose N.R. Cellular immunity: a role for cytokines. Handbook of Systemic Autoimmune Diseases, Vol. 1: The Heart in Systemic Autoimmune Diseases 2004, 3-17. Elsevier, Amsterdam. A. Doria, P. Pauletto (Eds.).
37. Felix S.B., Staudt A. Non-specific immunoadsorption in patients with dilated cardiomyopathy: mechanisms and clinical effects. Int. J. Cardiol. 2006, 112:30-33.
38. Felker G.M., Thompson R.E., Hare J.M., Hurban R.H., Clemetson D.E., Howard D.L., et al. Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy. N. Engl. J. Med. 2000, 342:1077-1084.
39. Ferrari I., Levin M.J., Wallukat G., Elies R., Lebesgue D., Chiale P., et al. Molecular mimicry between the immunodominant ribosomal protein P0 of Trypanosoma cruzi and a functional epitope on the human beta1-adrenergic receptor. J. Exp. Med. 1995, 182:59-65.
40. Fousteri G., Dave A., Morin B., Omid S., Croft M., von Herrath M.G. Nasal cardiac myosin peptide treatment and OX40 blockade protect mice from acute and chronic virally-induced myocarditis. J. Autoimmun. 2011, 36:210-220.
41. Friedrich M.G., Sechtem U., Schulz-Menger J., Holmvang G., Alakija P., Cooper L.T., et al. Cardiovascular magnetic resonance in myocarditis: a JACC White Paper. J. Am. Coll. Cardiol. 2009, 53:1475-1487.
42. Frustaci A., Chimenti C., Calabrese F., Pieroni M., Thiene G., Maseri A. Immunosuppressive therapy for active lymphocytic myocarditis. Virological and immunologic profile of responders versus nonresponders. Circulation 2003, 107:857-863.
43. Girones N., Rodriguez C.I., Carrasco-Marin E., Hernaez R.F., de Rego J.L., Fresno M. Dominant T- and B-cell epitopes in an autoantigen linked to Chagas' disease. J. Clin. Invest. 2001, 107:985-993.
44. Goser S., Andrassy M., Buss S.J., Leuschner F., Volz C.H., Ottl R., et al. Cardiac troponin I but not cardiac troponin T induces severe autoimmune inflammation in the myocardium. Circulation 2006, 114:1693-1702.
45. Gravanis M.B., Ansari A.A. Idiopathic cardiomyopathies. A review of pathologic studies and mechanisms of pathogenesis. Arch. Pathol. Lab. Med. 1987, 111:915-929.
46. Gravanis M.B., Sternby N.H. Incidence of myocarditis: a 10-year autopsy study from Malmö, Sweden. Arch. Pathol. Lab. Med. 1991, 115:390-392.
47. Grist N.R., Bell E.J. A six-year study of coxsackievirus B infections in heart disease. J. Hygiene 1974, 73:165-172.
48. Grogan M., Redfield M.M., Bailey K.R., Reeder G.S., Gersh B.J., Edwards W.D., et al. Long-term outcome of patients with biopsy-proved myocarditis: comparison with idiopathic dilated cardiomyopathy. J. Am. Coll. Cardiol. 1995, 26:80-84.
49. Gutberlet M., Spors B., Thoma T., Bertram H., Denecke T., Felix R., et al. Suspected chronic myocarditis at cardiac MR: diagnostic accuracy and association with immunohistologically detected inflammation and viral persistence. Radiology 2008, 246:401-409.
50. Hammond E.H., Menlove R.L., Anderson J.L. Immunofluorescence microscopy in the diagnosis and follow-up of myocarditis. A critical review. New Concepts in Viral Heart Disease 1988, 303-311. Springer-Verlag, Berlin. H.-P. Schultheiss (Ed.).
51. Hashimoto K., Yoshioka K. Review: surveillance of Chagas disease. Adv. Parasitol. 2012, 79:375-428.
52. Hauck A.J., Kearney D.L., Edwards W.D. Evaluation of postmortem endomyocardial biopsy specimens from 38 patients with lymphocytic myocarditis: implications for role of sampling error. Mayo Clinic. Proc. 1989, 64:1235-1245.
53. Hayward S.L., Bautista-Lopez N., Suzuki K., Atrazhev A., Dickie P., Elliott J.F. CD4 T cells play major effector role and CD8 T cells initiating role in spontaneous autoimmune myocarditis of HLA-DQ8 transgenic IAb knockout nonobese diabetic mice. J. Immunol. 2006, 176:7715-7725.
54. Herskowitz A., Ahmed-Ansari A., Neumann D.A., Beschorner W.E., Rose N.R., Soule L.M., et al. Induction of major histocompatibility complex antigens within the myocardium of patients with active myocarditis: a nonhistologic marker of myocarditis. J. Am. Coll. Cardiol. 1990, 15:624-632.
55. Horwitz M.S., La Cava A., Fine C., Rodriguez E., Ilic A., Sarvetnick N. Pancreatic expression of interferon-gamma protects mice from lethal coxsackievirus B3 infection and subsequent myocarditis. Nat. Med. 2000, 6:693-697.
56. Huber S.A. Animal models of human disease. Autoimmunity in myocarditis: relevance of animal models. Clin. Immunol. Immunopathol. 1997, 83:93-102.
57. Jacobson D.L., Gange S.J., Rose N.R., Graham N.M.H. Epidemiology and estimated population burden of selected autoimmune diseases in the United States. Clin. Immunol. Immunopathol. 1997, 84:223-243.
58. Jahns R., Schlipp A., Boivin V., Lohse M.J. Targeting receptor antibodies in immune cardiomyopathy. Semin. Thromb. Hemost. 2010, 36:212-218.
59. Jefferies J.L., Towbin J.A. Dilated cardiomyopathy. Lancet 2010, 375:752-762.
60. Jeserich M., Konstantinides S., Olschewski M., Pavlik G., Bode C., Geibel A. Diagnosis of early myocarditis after respiratory or gastrointestinal tract viral infection: insights from cardiovascular magnetic resonance. Clin. Res. Cardiol. 2010, 99:707-714.
61. Jones S.R., Herskowitz H.M., Hutchins H.M., Baughman K.L. Effects of immunosuppressive therapy in biopsy-proved myocarditis and borderline myocarditis on left ventricular function. Am. J. Cardiol. 1991, 68:370-376.
62. Kalil J., Cunha-Neto E. Autoimmunity in Chagas' disease cardiomyopathy: fulfilling the criteria at last?. Parasitol. Today 1996, 12:396-399.
63. Kandolf R., Ameis D., Kirschner P., Canue A., Hofschneider P.H. In situ detection of enteroviral genomes in myocardital cells by nucleic acid hybridization: an approach to the diagnosis of viral heart disease. Proc. Natl. Acad. Sci. USA 1987, 84:6272-6276.
64. Kaplan D., Ferrari I., Bergami P.L., Mahler E., Levitus G., Chiale P., et al. Antibodies to ribosomal P proteins of Trypanosoma cruzi in Chagas' disease possess functional autoreactivity with heart tissue and differ from anti-P autoantibodies in lupus. Proc. Natl. Acad. Sci. USA 1997, 94:10301-10306.
65. Kaya Z., Goser S., Buss S.J., Leuschner F., Ottl R., Li J., et al. Identification of cardiac troponin I sequence motifs leading to heart failure by induction of myocardial inflammation and fibrosis. Circulation 2008, 118:2063-2072.
66. Kaya Z., Katus H.A., Rose N.R. Cardiac troponins and autoimmunity: their role in the pathogenesis of myocarditis and of heart failure. Clin. Immunol. 2010, 134:80-88.
67. Kaya Z., Leib C., Katus H.A. Autoantibodies in heart failure and cardiac dysfunction. Circ. Res. 2012, 110:145-158.
68. Kline I.K., Saphir O. Chronic pernicious myocarditis. Am. Heart J. 1960, 59:681-697.
69. Klingel K.C., Hohenadl A., Canu M., Albrecht M., Seemann M., Mall G., et al. Ongoing enterovirus-induced myocarditis is associated with persistent heart muscle infection: quantitative analysis of virus replication, tissue damage, and inflammation. Proc. Natl. Acad. Sci. USA 1992, 89:314-318.
70. Kuo H.C., Yang K.D., Chang W.C., Ger L.P., Hsieh K.S. Kawasaki disease: an update on diagnosis and treatment. Pediatr. Neonatol. 2012, 53:4-11.
71. Kühl U., Schultheiss H.-P. Treatment of chronic myocarditis with corticosteroids. Eur. Heart J. 1995, 16:168-172.
72. Kühl U., Pauschinger M., Schwimmbeck P.L., Seeberg B., Lober C., Noutsias M., et al. Interferon-b treatment eliminates cardiotropic viruses and improves left ventricular function in patients with myocardial persistence of viral genomes and left ventricular dysfunction. Circulation 2003, 107:2793-2798.
73. Leuschner F., Li J., Goser S., Reinhardt L., Ottl R., Bride P., et al. Absence of auto-antibodies against cardiac troponin I predicts improvement of left ventricular function after acute myocardial infarction. Eur. Heart 2008, 29:1949-1955.
74. Levander O.A., Beck M.A. Interacting nutritional and infectious etiologies of Keshan disease. Insights from Coxsackie virus B-induced myocarditis in mice deficient in selenium or vitamin E. Biol. Trace. Elem. Res. 1997, 56:1-16.
75. Li H.S., Ligons D.L., Rose N.R. Genetic complexity of autoimmune myocarditis. Autoimmun. Rev. 2008, 7:168-173.
76. Li H.S., Ligons D.L., Rose N.R., Guler M.L. Genetic differences in bone marrow-derived lymphoid lineages control susceptibility to experimental autoimmune myocarditis. J. Immunol. 2008, 180:7480-7484.
77. Liberthson R.R. Sudden death from cardiac causes in children and young adults. N. Engl. J. Med. 1996, 334:1039-1044.
78. Lieberman E.B., Hutchins G.M., Herskowitz A., Rose N.R., Baughman K.L. Clinicopathologic description of myocarditis. J. Am. Coll. Cardiol. 1991, 18:1617-1626.
79. Lieberman E.B., Herskowitz A., Rose N.R., Baughman K.L. A clinicopathologic description of myocarditis. Clin. Immunol. Immunopathol. 1993, 68:191-196.
80. Limas C.J., Goldenberg I.F., Limas C. Autoantibodies against beta-adrenoreceptors in human idiopathic dilated cardiomyopathy. Circ. Res. 1989, 64:97-103.
81. Limas C.J., Limas C., Kubo S.H., Olivari M.T. Anti-beta receptor antibodies in human dilated cardiomyopathy and correlation with HLA-DR antigens. Am. J. Cardiol. 1990, 65:483-487.
82. Luppi P., Rudert W., Licata A., Riboni S., Betters D., Cotrufo M., et al. Expansion of specific αβ+ T-cell subsets in the myocardium of patients with myocarditis and idiopathic dilated cardiomyopathy associated with Coxsackievirus B infection. Hum. Immunol. 2003, 64:194-210.
83. Magnani J.W., Danik H.J., Dec G.W., DiSalvo T.G. Survival in biopsy-proven myocarditis: a long-term retrospective analysis of the histopathologic, clinical, and hemodynamic predictors. Am. Heart J. 2006, 151:463-470.
84. Mahon N.G., Madden B.P., Caforio A.L.P., Elliott P.M., Haven A.J., Keogh B.E., et al. Immunohistologic evidence of myocardial disease in apparently healthy relatives of patients with dilated cardiomyopathy. J. Am. Coll. Cardiol. 2002, 39:455-462.
85. Mahrholdt H., Goedecke C., Wagner A., Meinhardt G., Athanasiadis A., Vogelsberg H., et al. Cardiovascular magnetic resonance assessment of human myocarditis: a comparison to histology and molecular pathology. Circulation 2004, 109:1250-1258.
86. Maisch B. Immune regulation, humoral and cell-mediated immune reactions in myocarditis and dilated cardiomyopathy. Pathogenesis of Myocarditis and Cardiomyopathy 1987, 245-267. University of Tokyo Press, Tokyo. C. Kawai, W.H. Abelmann (Eds.).
87. Maisch B., Berg P.A., Kochsiek K. Clinical significance of immunopathological findings in patients with post-periocardiotomy syndrome. I. Relevance of antibody pattern. Clin. Exp. Immunol. 1979, 38:189-197.
88. Maisch B., Portig I., Ristic A., Hufnagel G., Pankuweit S. Definition of inflammatory cardiomyopathy (myocarditis): on the way to consensus. A status report. Herz 2000, 25:200-209.
89. Maisch B., Hufnagel G., Kolsch S., Funck R., Richter A., Rupp H., et al. Treatment of inflammatory dilated cardiomyopathy and (Peri)myocarditis with immunosuppression and i.v. immunoglobulins. Herz 2004, 29:624-636.
90. Mason J.W., O'Connell J.B. Clinical merit of endomyocardial biopsy. Circulation 1989, 79:971-979.
91. Mason J.W., O'Connell J.B., Herskowitz A., Rose N.R., McManus B.M., Billingham M.E., et al. A clinical trial of immunosuppressive therapy for myocarditis. N. Engl. J. Med. 1995, 333:269-275.
92. McCarthy R.M., Boehmer J.P., Hruban R.H., Hutchins G.M., Kasper E.K., Hare J.M., et al. Long-term outcome of fulminant myocarditis as compared with acute (nonfulminant) myocarditis. N. Engl. J. Med. 2000, 342:690-695.
93. McNamara D.M., Holubko V.R., Starling R.C., Dee G.W., Loh E., Tirre-Amione G., et al. Controlled trial of intravenous immunoglobulin in recent onset dilated cardiomyopathy. Circulation 2001, 103:2254-2259.
94. Miklozek C.L., Kingsley E.M., Crumpaker C.S., Modlin J.F., Royal Henry D., Come P.C., et al. Serial cardiac function tests in myocarditis. Postgrad. Med. J. 1986, 62:577-579.
95. Miric M., Miskovic A., Brkic S., Vasiljevic J., Keserovic N., Pesic M. Long-term follow-up of patients with myocarditis and idiopathic dilated cardiomyopathy after immunomodulatory therapy. FEMS Immunol. Med. Microbiol. 1994, 10:65-74.
96. Motran C.C., Fretes R.E., Cerban F.M., Rivarola H.W., Bottero de Cima E. Immunization with the C-terminal region of Trypanosoma cruzi ribosomal P1 and P2 proteins induces long-term duration cross-reactive antibodies with heart functional and structural alterations in young and aged mice. Clin. Immunol. 2000, 97:89-94.
97. Müller J., Wallukat G., Dandel M., Bieda H., Brandes K., Spiegelsberger S., et al. Immunoglobulin adsorption in patients with idiopathic dilated cardiomyopathy. Circulation 2000, 101:385-401.
98. Nagatomo Y., Baba A., Ito H., Naito K., Yoshizawa A., Kurita Y., et al. Specific immunoadsorption therapy using a tryptophan column in patients with refractory heart failure due to dilated cardiomyopathy. J. Clin. Apher. 2011, 26:1-8.
99. Neu N., Beisel K.W., Traystman M.D., Rose N.R., Craig S.W. Autoantibodies specific for the cardiac myosin isoform are found in mice susceptible to Coxsackievirus B3-induced myocarditis. J. Immunol. 1987, 138:2488-2492.
100. Neu N., Rose N.R., Beisel K.W., Herskowitz A., Gurri-Glass G., Craig S.W. Cardiac myosin induces myocarditis in genetically predisposed mice. J. Immunol. 1987, 139:3630-3636.
101. Neumann D.A., Burek C.L., Baughman K.L., Rose N.R., Herskowitz A. Circulating heart-reactive antibodies in patients with myocarditis or cardiomyopathy. J. Am. Coll. Cardiol. 1990, 16:839-846.
102. Noren G.R., Staley N.A., Bandt C.M., Kaplan E.L. Occurrence of myocarditis in sudden death in children. J. Forensic Sci. 1976, 22:188-196.
103. Parrillo J.E., Cunnion R.E., Epstein S.E., Parker M.M., Suffredini A.F., Brenner M., et al. A prospective, randomized, controlled trial of prednisone for dilated cardiomyopathy. N. Engl. J. Med. 1989, 321:1061-1068.
104. Pauschinger M., Chandrasekharan K., Noutsias M., Kühl U., Schwimmbeck L.P., Schultheiss H.-P. Viral heart disease: molecular diagnosis, clinical prognosis, and treatment strategies. Med. Microbiol. Immunol. (Berl.) 2004, 193:65-69.
105. Pellegrini A., Guinazu N., Giordanengo L., Cano R.C., Gea S. The role of Toll-like receptors and adaptive immunity in the development of protective or pathological immune response triggered by the Trypanosoma cruzi protozoan. Future Microbiol. 2012, 6:1521-1533.
106. Petretta M., Pirozzi F., Sasso L., Paglia A., Bonaduce D. Review and metaanalysis of the frequency of familial dilated cardiomyopathy. Am. J. Cardiol. 2011, 108:1171-1176.
107. Rose N.R. Viral damage or "molecular mimicry": placing the blame in myocarditis. Nat. Med. 2000, 6:5-6.
108. Rose N.R. Critical cytokine pathways to cardiac inflammation. J. Interferon Cytokine Res. 2011, 31(10):705-710.
109. Rose N.R., Hill S.L. The pathogenesis of postinfectious myocarditis. Clin. Immunol. Immunopathol. 1996, 80:S92-S99.
110. Rose N.R., Beisel K.W., Herskowitz A., Neu N., Wolfgram L.J., Alvarez F.L., et al. Cardiac myosin and autoimmune myocarditis. Ciba Symposium 129 1987, 3-24. John Wiley & Sons, Chichester. D. Evered, J. Whelan (Eds.).
111. Rose N.R., Neumann D.A., Herskowitz A., Traystman M., Beisel K.W. Genetics of susceptibility to viral myocarditis in mice. Pathol. Immunopathol. Res. 1988, 7:266-278.
112. Sagar S., Liu P.P., Cooper J.T. Myocarditis. Lancet 2012, 379:738-747.
113. Schultheiss H.-P., Schulze K., Kühl U., Ulrich G., Klingenberg M. The ADP/ATP carrier as a mitochondrial auto-antigen-facts and perspectives. Ann. N.Y. Acad. Sci. 1986, 488:44-64.
114. Schultheiss H.P., Kuhl U. Why is diagnosis of infectious myocarditis such a challenge?. Expert Rev. Anti. Infect. Ther. 2011, 9:1093-1095.
115. Smith S.C., Allen P.M. Myosin-induced acute myocarditis is a T cell-mediated disease. J. Immunol. 1991, 147:2141-2147.
116. Staudt A., Böhm M., Knebel F., Grosse Y., Bischoff C., Hummel A., et al. Potential role of autoantibodies belonging to the immunoglobulin G-3 subclass in cardiac dysfunction among patients with dilated cardiomyopathy. Circulation 2002, 106:2448-2453.
117. Staudt Y., Mobini R., Fu M., Felix S.B., Kuhn J.P., Staudt A. Beta1-adrenoceptor antibodies induce apoptosis in adult isolated cardiomyocytes. Eur. J. Pharmacol. 2003, 466:1-6.
118. Stewart G.C., Lopez-Molina J., Gottumukkala R.V., Rosner G.F., Anello M.S., Hecht J.L., et al. Myocardial parvovirus B19 persistence: lack of association with clinicopathologic phenotype in adults with heart failure. Circ. Heart Fail 2011, 4:71-78.
119. Taneja V., David C.S. Spontaneous autoimmune myocarditis and cardiomyopathy in HLA-DQ8.NODAbo transgenic mice. J. Autoimmun. 2009, 33:260-269.
120. Torp A. Incidence of congestive cardiomyopathy. Congestive Cardiomyopathy. A.B. Hässle, Molndal 1981, 18-22. J.F. Goodwin, A. Hjalmarson, E.G.J. Olsen (Eds.).
121. Towbin J.A., Li H., Taggart R.T., Lehman M.H., Schwartz P.J., Satler C.A., et al. Molecular and cellular cardiovascular medicine: evidence of genetic heterogeneity in Romano-Ward long QT syndrome: analysis of 23 families. Circulation 1994, 90:2635-2644.
122. Tracy S., Chapman N.M., Romero J., Ramsingh A.I. Genetics of coxsackievirus B cardiovirulence and inflammatory heart muscle disease. Trends Microbiol. 1996, 4:175-179.
123. Van Voorhis W.C., Schlekewy L., Trong H.L. Molecular mimicry by Tryponosoma cruzi: the Fl-160 epitope that mimics mammalian nerve can be mapped to a 12-amino acid peptide. Proc. Natl. Acad. Sci. USA. 1991, 88:5993-5997.
124. Wang Y., Afanasyeva M., Hill S.L., Kaya A., Rose N.R. Nasal administration of cardiac myosin suppresses autoimmune myocarditis in mice. J. Am. Coll. Cardiol. 2000, 36:1992-1999.
125. Wessely R., Henke A., Zell R., Kandolf R., Knowlton K.U. Low-level expression of a mutant coxsackieviral cDNA induces a myocytopathic effect in culture: an approach to the study of enteroviral persistence in cardiac myocytes. Circulation 1998, 98:450-457.
126. Williams D.G., Olsen E.G.L. Prevalence of overt dilated cardiomyopathy in two regions of England. Br. Heart J. 1985, 54:153-155.
127. Winters J.L. Apheresis in the treatment of idiopathic dilated cardiomyopathy. J. Clin. Apher 2012, 27:312-319.
128. Wojnicz R., Nawalany-Kozielska E., Wojciechowska C., Glanowska G., Wilczewski P., Niklewski T., et al. Randomized, placebo-controlled study for immunosuppressive treatment of inflammatory dilated cardiomyopathy: two-year follow-up results. Circulation 2001, 104:39-45.
129. Wolff P., Kühl U., Schultheiss H.-P. Laminin distribution and autoantibodies in idiopathic dilated cardiomyopathy and myocarditis. Am. Heart J. 1989, 117:1303-1309.